Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The temperature-controlled packaging solutions for the pharmaceuticals market is expected to record an above-average growth rate during the forecast period. The key end use industries for the temperature-controlled packaging solutions for pharmaceuticals are healthcare, biomedical, and chemical industries.
Given the increase in demand for a conducive environment for pharmaceuticals, efforts have been made by manufacturers to work on the quality of the perishable pharma products.
In addition, the intervention of the central healthcare bodies is also a key influencer driving the growth of the temperature-controlled packaging solutions for the pharmaceuticals market.
For instance, the Food and Drug Administration (FDA) in the U.S. has defined a regulation under distribution procedures, which states that pharmaceuticals are to be shipped with the right temperatures.
As a result, companies operating in the temperature-controlled packaging solutions for the pharmaceuticals market are looking at electronic temperature and humidity equipment for the proper delivery and dispatch of the delivery drugs.
During the spread of the pandemic, the temperature-controlled packaging solutions for the pharmaceuticals market witnessed a significant boost, as dependency on healthcare and pharmaceutical was high among individuals. Besides this, multiple uses of temperature-controlled packaging solutions for vaccines and other medicines to cure and prevent coronavirus are expected to amplify the market growth during the forecast period.
On the flip side, there have been several deterrents that are impacting the moderate growth of the temperature-controlled packaging solutions for the pharmaceuticals market. Among the others, low awareness regarding the availability of technology to maintain the right temperature for pharmaceutical packaging in some parts of the developing countries is impacting the true market potential.
In addition, the cost of advanced temperature-controlled packaging is a key concern for numerous pharmaceutical companies. This could hamper the growth pace of the temperature-controlled packaging solutions for the pharmaceuticals market during the forecast period.
Strong Emphasis on Waste Reduction of Critical Biologics to Boost Demand
The global demand for temperature-sensitive vaccines is anticipated to grow 6-7% annually. International organizations, such as World Health Organization (WHO), are continuously focusing on reducing wastage of vaccines across the globe.
For instance, in 2012, World Health Organization estimated global liquid vaccine wastage at a staggering 25%, primarily attributed to disruptions in cold chain supply.
As a part of this, various programs have been initiated to monitor vaccine wastage. These programs also focus on proper handling and transportation of vaccines and in turn, are driving the demand for temperature controlled packaging.
Principal Consultant
The need for better handling of temperature-sensitive pharmaceutical products has resulted in increased research for more advanced temperature controlled packaging insulation materials such as VIP, PCMs, and sheep wool.
VIP-based insulation and PCM-based refrigerants offer major advantages over conventional expanded polystyrene (EPS) and polyurethane insulated shippers. Shippers implementing VIPs and PCMs are relatively lightweight, provide wide temperature ranges, cut distribution costs, and thus, are gaining market share.
Cold chain packaging, particularly for pharmaceuticals is exposed to rigorous climatic conditions, wherein the packaged pharmaceutical products are shipped through different modes of transportation, including ocean transportation. This increases the risk of direct exposure of the packaged product to sunlight, dwell time on the dock, and stress on the package due to other products in the container.
As only a handful of manufacturers test their pharmaceutical packaging products to bear such stress, not all suppliers can meet client requirements. Therefore, a large portion of the industry is facing issues related to temperature controlled pharmaceutical packaging product performance across different climatic conditions and thus, do not meet quality standards.
Furthermore, exhibiting minimal or no external environment impact on the stored product is also important for pharmaceutical companies, as there are reported incidences wherein variation in the pharmaceutical product’s storage temperature resulted into a profound impact on drug’s stability and therapeutic efficacy.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2015 to 2019 |
| Historical Data Available for | 2020 to 2030 |
| Market Analysis | US$ Million for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific Excluding Japan; Japan and Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Germany, Brazil, Mexico, Rest of Latin America, UK, France, Italy, Spain, Rest of Europe, Nordic, BENELUX, Rest of Western Europe, Russia, Poland, Rest of Eastern Europe, ASEAN, Japan, India, China, South Korea, Rest of Asia Pacific excluding Japan, Australia, New Zealand, GCC, North Africa, South Africa, Rest of MEA |
| Key Segments Covered | Product, Application, Region |
| Key Companies Profiled | Sonoco Products Company; Pelican Biothermal; Sofrigam SA Ltd.; Cryopak; Cold Chain Technologies; Envirotainer Ltd.; va-Q-tec AG; Inmark Packaging; American Aerogel Corporation |
| Report Coverage | Market Overview, Key Market Trends, Key Success Factors, Demand Analysis, Market Background, COVID-19 Analysis, Segmental Analysis, Regional Profiling, Market Structure & Competition Analysis |
| Customization & Pricing | Available Upon Request |
On the basis of product type :
On the basis of application :
The temperature-controlled packaging solutions for pharmaceuticals market is likely to secure a CAGR of 7.8% through 2032.
The temperature-controlled packaging solutions for pharmaceuticals market size is estimated to cross US$ 10.02 Bn by 2032.
The temperature-controlled packaging solutions for pharmaceuticals market is likely to record a value of US$ 4.73 Bn in 2022.
North America is likely to lead the temperature-controlled packaging solutions for pharmaceuticals market.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Opportunity
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Market Background
3.1. Porter’s Analysis
3.2. Macro-Economic Factors
3.3. Forecast Factors – Relevance & Impact
3.4. Value Chain Analysis & Profitability Margin
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Trends
3.6. Opportunity Analysis
4. Market Forecast
4.1. Market Volume Projections
4.2. Pricing Analysis
4.3. Market Size Projections
4.4. Y-o-Y Projections
4.5. Absolute $ Opportunity Analysis
5. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis By Product Type
5.1. Introduction
5.1.1. Market Value Share Analysis By Product Type
5.1.2. Y-o-Y Growth Analysis By Product Type
5.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
5.2.1. Insulated Shippers
5.2.1.1. Panels and Envelopes
5.2.1.2. EPS Foam Container
5.2.1.3. Fiberboard
5.2.1.4. PUR
5.2.2. Insulated Protective Shippers
5.2.3. Insulated Containers
5.2.3.1. Chest Style
5.2.3.2. Upright Style
5.2.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
5.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
5.3.1. Insulated Shippers
5.3.1.1. Panels and Envelopes
5.3.1.2. EPS Foam Container
5.3.1.3. Fiberboard
5.3.1.4. PUR
5.3.2. Insulated Protective Shippers
5.3.3. Insulated Containers
5.3.3.1. Chest Style
5.3.3.2. Upright Style
5.3.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
5.4. Market Attractiveness Analysis By Product Type
6. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis By Application
6.1. Introduction
6.1.1. Market Value Share Analysis By Application
6.1.2. Y-o-Y Growth Analysis By Application
6.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
6.2.1. Frozen
6.2.2. Chilled
6.2.3. Ambient
6.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
6.3.1. Frozen
6.3.2. Chilled
6.3.3. Ambient
6.4. Market Attractiveness Analysis By Application
7. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis By Region
7.1. Introduction
7.1.1. Market Value Share Analysis By Region
7.1.2. Y-o-Y Growth Analysis By Region
7.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Western Europe
7.2.4. Eastern Europe
7.2.5. Asia Pacific
7.2.6. MEA
7.2.7. Japan
7.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. Asia Pacific
7.3.6. MEA
7.3.7. Japan
7.4. Market Attractiveness Analysis By Region
8. North America Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis
8.1. Introduction
8.2. Regional Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country
8.3.1. U.S.
8.3.2. Canada
8.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country
8.4.1. U.S.
8.4.2. Canada
8.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
8.5.1. Insulated Shippers
8.5.1.1. Panels and Envelopes
8.5.1.2. EPS Foam Container
8.5.1.3. Fiberboard
8.5.1.4. PUR
8.5.2. Insulated Protective Shippers
8.5.3. Insulated Containers
8.5.3.1. Chest Style
8.5.3.2. Upright Style
8.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
8.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
8.6.1. Insulated Shippers
8.6.1.1. Panels and Envelopes
8.6.1.2. EPS Foam Container
8.6.1.3. Fiberboard
8.6.1.4. PUR
8.6.2. Insulated Protective Shippers
8.6.3. Insulated Containers
8.6.3.1. Chest Style
8.6.3.2. Upright Style
8.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
8.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
8.7.1. Frozen
8.7.2. Chilled
8.7.3. Ambient
8.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
8.8.1. Frozen
8.8.2. Chilled
8.8.3. Ambient
8.9. Market Trends
8.10. Key Market Participants – Intensity Mapping
8.11. Drivers and Restraints – Impact Analysis
9. Latin America Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis
9.1. Introduction
9.2. Regional Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country
9.3.1. Brazil
9.3.2. Mexico
9.3.3. Rest of Latin America
9.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
9.5.1. Insulated Shippers
9.5.1.1. Panels and Envelopes
9.5.1.2. EPS Foam Container
9.5.1.3. Fiberboard
9.5.1.4. PUR
9.5.2. Insulated Protective Shippers
9.5.3. Insulated Containers
9.5.3.1. Chest Style
9.5.3.2. Upright Style
9.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
9.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
9.6.1. Insulated Shippers
9.6.1.1. Panels and Envelopes
9.6.1.2. EPS Foam Container
9.6.1.3. Fiberboard
9.6.1.4. PUR
9.6.2. Insulated Protective Shippers
9.6.3. Insulated Containers
9.6.3.1. Chest Style
9.6.3.2. Upright Style
9.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
9.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
9.7.1. Frozen
9.7.2. Chilled
9.7.3. Ambient
9.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
9.8.1. Frozen
9.8.2. Chilled
9.8.3. Ambient
9.9. Market Trends
9.10. Key Market Participants – Intensity Mapping
9.11. Drivers and Restraints – Impact Analysis
10. Western Europe Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis
10.1. Introduction
10.2. Regional Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country
10.3.1. Germany
10.3.2. Italy
10.3.3. France
10.3.4. Spain
10.3.5. U.K.
10.3.6. Nordic
10.3.7. Benelux
10.3.8. Rest of Western Europe
10.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country
10.4.1. Germany
10.4.2. Italy
10.4.3. France
10.4.4. Spain
10.4.5. U.K.
10.4.6. Nordic
10.4.7. Benelux
10.4.8. Rest of Western Europe
10.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
10.5.1. Insulated Shippers
10.5.1.1. Panels and Envelopes
10.5.1.2. EPS Foam Container
10.5.1.3. Fiberboard
10.5.1.4. PUR
10.5.2. Insulated Protective Shippers
10.5.3. Insulated Containers
10.5.3.1. Chest Style
10.5.3.2. Upright Style
10.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
10.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
10.6.1. Insulated Shippers
10.6.1.1. Panels and Envelopes
10.6.1.2. EPS Foam Container
10.6.1.3. Fiberboard
10.6.1.4. PUR
10.6.2. Insulated Protective Shippers
10.6.3. Insulated Containers
10.6.3.1. Chest Style
10.6.3.2. Upright Style
10.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
10.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
10.7.1. Frozen
10.7.2. Chilled
10.7.3. Ambient
10.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
10.8.1. Frozen
10.8.2. Chilled
10.8.3. Ambient
10.9. Market Trends
10.10. Key Market Participants – Intensity Mapping
10.11. Drivers and Restraints – Impact Analysis
11. Eastern Europe Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis
11.1. Introduction
11.2. Regional Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country
11.3.1. Russia
11.3.2. Poland
11.3.3. Rest of Eastern Europe
11.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country
11.4.1. Russia
11.4.2. Poland
11.4.3. Rest of Eastern Europe
11.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
11.5.1. Insulated Shippers
11.5.1.1. Panels and Envelopes
11.5.1.2. EPS Foam Container
11.5.1.3. Fiberboard
11.5.1.4. PUR
11.5.2. Insulated Protective Shippers
11.5.3. Insulated Containers
11.5.3.1. Chest Style
11.5.3.2. Upright Style
11.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
11.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
11.6.1. Insulated Shippers
11.6.1.1. Panels and Envelopes
11.6.1.2. EPS Foam Container
11.6.1.3. Fiberboard
11.6.1.4. PUR
11.6.2. Insulated Protective Shippers
11.6.3. Insulated Containers
11.6.3.1. Chest Style
11.6.3.2. Upright Style
11.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
11.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
11.7.1. Frozen
11.7.2. Chilled
11.7.3. Ambient
11.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
11.8.1. Frozen
11.8.2. Chilled
11.8.3. Ambient
11.9. Market Trends
11.10. Key Market Participants – Intensity Mapping
11.11. Drivers and Restraints – Impact Analysis
12. Middle East and Africa Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country
12.3.1. Northern Africa
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of Middle East and Africa
12.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country
12.4.1. Northern Africa
12.4.2. GCC Countries
12.4.3. South Africa
12.4.4. Rest of Middle East and Africa
12.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
12.5.1. Insulated Shippers
12.5.1.1. Panels and Envelopes
12.5.1.2. EPS Foam Container
12.5.1.3. Fiberboard
12.5.1.4. PUR
12.5.2. Insulated Protective Shippers
12.5.3. Insulated Containers
12.5.3.1. Chest Style
12.5.3.2. Upright Style
12.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
12.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
12.6.1. Insulated Shippers
12.6.1.1. Panels and Envelopes
12.6.1.2. EPS Foam Container
12.6.1.3. Fiberboard
12.6.1.4. PUR
12.6.2. Insulated Protective Shippers
12.6.3. Insulated Containers
12.6.3.1. Chest Style
12.6.3.2. Upright Style
12.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
12.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
12.7.1. Frozen
12.7.2. Chilled
12.7.3. Ambient
12.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
12.8.1. Frozen
12.8.2. Chilled
12.8.3. Ambient
12.9. Market Trends
12.10. Key Market Participants – Intensity Mapping
12.11. Drivers and Restraints – Impact Analysis
13. Asia Pacific Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country
13.3.1. China
13.3.2. India
13.3.3. ASEAN
13.3.4. Australia and New Zealand
13.3.5. Rest of APEJ
13.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country
13.4.1. China
13.4.2. India
13.4.3. ASEAN
13.4.4. Australia and New Zealand
13.4.5. Rest of APEJ
13.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
13.5.1. Insulated Shippers
13.5.1.1. Panels and Envelopes
13.5.1.2. EPS Foam Container
13.5.1.3. Fiberboard
13.5.1.4. PUR
13.5.2. Insulated Protective Shippers
13.5.3. Insulated Containers
13.5.3.1. Chest Style
13.5.3.2. Upright Style
13.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
13.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
13.6.1. Insulated Shippers
13.6.1.1. Panels and Envelopes
13.6.1.2. EPS Foam Container
13.6.1.3. Fiberboard
13.6.1.4. PUR
13.6.2. Insulated Protective Shippers
13.6.3. Insulated Containers
13.6.3.1. Chest Style
13.6.3.2. Upright Style
13.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
13.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
13.7.1. Frozen
13.7.2. Chilled
13.7.3. Ambient
13.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
13.8.1. Frozen
13.8.2. Chilled
13.8.3. Ambient
13.9. Market Trends
13.10. Key Market Participants – Intensity Mapping
13.11. Drivers and Restraints – Impact Analysis
14. Japan Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type
14.3.1. Insulated Shippers
14.3.1.1. Panels and Envelopes
14.3.1.2. EPS Foam Container
14.3.1.3. Fiberboard
14.3.1.4. PUR
14.3.2. Insulated Protective Shippers
14.3.3. Insulated Containers
14.3.3.1. Chest Style
14.3.3.2. Upright Style
14.3.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
14.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type
14.4.1. Insulated Shippers
14.4.1.1. Panels and Envelopes
14.4.1.2. EPS Foam Container
14.4.1.3. Fiberboard
14.4.1.4. PUR
14.4.2. Insulated Protective Shippers
14.4.3. Insulated Containers
14.4.3.1. Chest Style
14.4.3.2. Upright Style
14.4.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.)
14.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application
14.5.1. Frozen
14.5.2. Chilled
14.5.3. Ambient
14.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application
14.6.1. Frozen
14.6.2. Chilled
14.6.3. Ambient
14.7. Market Trends
14.8. Key Market Participants – Intensity Mapping
14.9. Drivers and Restraints – Impact Analysis
15. Market Structure Analysis
15.1. Market Analysis by Tier of Companies
15.1.1. By Large, Medium and Small
15.2. Market Concentration
15.2.1. By Top 5 and by Top 10
15.3. Production Material Share Analysis
15.3.1. BY Large, Medium and Small
15.3.2. By Top 5 and Top 10
15.4. Market Share Analysis of Top 10 Players
15.4.1. North America Market Share Analysis by Top Players
15.4.2. Europe Market Share Analysis by Top Players
15.4.3. Asia Pacific Market Share Analysis by Top Players
15.4.4. Latin America Market Share Analysis by Top Players
15.4.5. MEA Market Share Analysis by Top Players
15.5. Market Presence Analysis
15.5.1. By Regional Footprint of Players
15.5.2. Product Footprint by Players
15.5.3. Channel Foot Print by Players
15.6. Technology Roadmap
16. Competition Analysis
16.1. Competition Dashboard
16.2. Pricing Analysis By Competition
16.3. Competition Benchmarking
16.4. Profitability and Gross Margin Analysis By Competition
16.5. Competition Developments
16.6. Competition Deep Dive (20 Companies)
16.6.1. Sonoco Products Company
16.6.1.1. Overview
16.6.1.2. Product Portfolio
16.6.1.3. Profitability
16.6.1.4. Production Footprint
16.6.1.5. Sales Footprint
16.6.1.6. Channel Footprint
16.6.1.7. Competition Benchmarking
16.6.1.8. Strategy
16.6.1.8.1. Marketing Strategy
16.6.1.8.2. Product Strategy
16.6.1.8.3. Channel Strategy
16.6.2. Pelican Biothermal
16.6.3. Sofrigam SA Ltd.
16.6.4. Cryopak
16.6.5. Cold Chain Technologies
16.6.6. Envirotainer Ltd.
16.6.7. va-Q-tec AG
16.6.8. Inmark Packaging
16.6.9. American Aerogel Corporation
16.6.10. Snyder Industries, Inc.
16.6.11. ACH Foam Technologies, LLC
16.6.12. Tempack Packaging Solutions, S.L.
16.6.13. EcoCool GmbH
16.6.14. Exeltainer SL
16.6.15. Intelsius
16.6.16. Inno Cool India Private Limited
16.6.17. Softbox Systems
16.6.18. Insulated Products Corporation
16.6.19. TKT GmbH
16.6.20. Saeplast America Inc.
16.6.21. Emball’ISO
17. Research Methodology
18. Assumptions & Acronyms
Explore Packaging Insights
View Reports
Temperature Controlled Packaging Solutions for Pharmaceuticals Market
